Center for Financial Planning, Inc.
Position in ADMA — Adma Biologics, Inc.
CIK 1803557
SOUTHFIED, MI
Position in ADMA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$12,555
-$960 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#267
of 320 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Center for Financial Planning, Inc. holds $31,192 across 7 Biotechnology names. ADMA ranks #2 (40.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
210 | $14,706 | |
| 2 | ADMA |
Adma Biologics, Inc.
This page
|
1,500 | $12,555 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
50 | $1,716 | |
| 4 | MNKD |
Mannkind Corp
|
354 | $1,508 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
10 | $545 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
50 | $162 | |
| 7 | IBO |
Impact Biomedical Inc.
|
0 | $0 |
All Filings in ADMA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,555 | 1,500 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $13,515 | 1,500 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $27,360 | 1,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $21,990 | 1,500 | Shares | Sole | 2025-11-06 | |
| 2021-06-30 | $608 | 380 | Shares | Sole | 2021-07-29 | |
| No filing history on record for this holder in this stock. | ||||||